NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 266 / 982

  1. Neuro-functional modeling of near-death experiences in contexts of altered states of consciousness2023 · Crossref
  2. Neuro-Gastro-Cannabinology: A Novel Paradigm for Regulating Mood and Digestive Health2023 · Crossref
  3. Neurobehavioral Profiles of Six Genetically-based Rat Models of Schizophrenia- related Symptoms2023 · OpenAlex
  4. Neurobiological and genetic correlates of the dissociative subtype of posttraumatic stress disorder.2023 · OpenAlex
  5. Neurobiological Correlates of Psilocybin Response in Depression2023 · OpenAlex
  6. Neurobiological Correlates Shared Between Obesity, BED and Food Addiction2023 · Crossref
  7. Neurogenetics and Epigenetics of Loneliness2023 · OpenAlex
  8. Neuroimaging in Adolescents: Post-Traumatic Stress Disorder and Risk for Substance Use Disorders2023 · Crossref
  9. Neuroimaging in psychedelic drug development: past, present, and future2023 · Crossref
  10. Neuroimaging the effects of smartphone (over-)use on brain function and structure—a review on the current state of MRI-based findings and a roadmap for future research2023 · OpenAlex
  11. Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay2023 · OpenAlex
  12. Neurologic Injury-Related Predisposing Factors of Post-Traumatic Stress Disorder: A Critical Examination2023 · OpenAlex
  13. Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings2023 · OpenAlex
  14. Neuromodulation and Opioid Use Disorder: Ethical Opportunities for Canada2023 · OpenAlex
  15. Neuropharmacological Modulation of N-methyl-D-aspartate, Noradrenaline and Endocannabinoid Receptors in Fear Extinction Learning: Synaptic Transmission and Plasticity2023 · OpenAlex
  16. Neuropharmacology Potential of the Hydroalcoholic Extract from the Leaves of Piper cernuum: Anxiolytic, Hypnotic, and Antidepressant‐Like Effects2023 · OpenAlex
  17. Neurophysiological error processing and addiction self‐awareness correlates of reduced insight in cannabis use disorder2023 · Crossref
  18. Neuroplastic Changes in Addiction Memory—How Music Therapy and Music-Based Intervention May Reduce Craving: A Narrative Review2023 · OpenAlex
  19. Neuroprotective Effect of Levetiracetam in Combination with Berberine on Scopolamine Induced-Cognitive Impairment in Mice: A Behavioral and Biochemical Approach2023 · Crossref
  20. Neuroprotective Effects of a Serotonin Receptor Peptide Follow-ing Sham vs. Mild Traumatic Brain Injury in the Zucker Rat2023 · OpenAlex
  21. Neuroprotective Effects of a Serotonin Receptor Peptide Following Sham vs. Mild Traumatic Brain Injury in the Zucker Rat2023 · OpenAlex
  22. Neuroprotective effects of morroniside from Cornus officinalis sieb. Et zucc against Parkinson’s disease via inhibiting oxidative stress and ferroptosis2023 · OpenAlex
  23. Neurosteroid influence on affective tone2023 · OpenAlex
  24. Neurotoxic Effect of Ethanol and Other Psychoactive Substances as a General Pathological Basis of Toxic Encephalopathy2023 · Crossref
  25. New advances of adiponectin in regulating obesity and related metabolic syndromes2023 · OpenAlex
  26. New Approach for Treatment-Resistant Depression2023 · OpenAlex
  27. New designer drugs: An emergent community challenge2023 · OpenAlex
  28. New Findings in the Ethnobotany of Uzbekistan2023 · Crossref
  29. New grants: Residential SUD treatment for pregnant women2023 · Crossref
  30. New Hopes in Psychopharmacology2023 · Crossref
  31. New Low Morphine Opium Poppy Genotype Obtained by TILLING Approach2023 · Crossref
  32. New naloxone spray approved for reversing overdoses2023 · Crossref
  33. New perspectives on how to formulate alcohol drinking guidelines2023 · Crossref
  34. New Psychoactive Substances in the Homeless Population: A Cross-Sectional Study in the United Kingdom2023 · OpenAlex
  35. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic2023 · Crossref
  36. New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session2023 · Crossref
  37. New Psychoactive Substances: A Potential Threat to Developing Countries2023 · Crossref
  38. New psychoactive substances: kratom, DMT, serotonergic hallucinogens, dissociative drugs. The mechanism of action, psychoactive effects2023 · Crossref
  39. New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions2023 · OpenAlex
  40. New research finds MDMA effective in treating severe PTSD2023 · Crossref
  41. NEW SECTION AND NEW SPECIES OF A BLUING PSILOCYBE (FUNGI, BASIDIOMYCOTINA, AGARICALES) FROM COLOMBIA2023 · OpenAlex
  42. New Synthetic Opioids: Clinical Considerations and Dangers2023 · OpenAlex
  43. New Zealand community pharmacists’ perspectives on supplying smoked tobacco as an endgame initiative: a qualitative analysis2023 · Crossref
  44. Newtypes, Angels, and Human Instrumentality: The Mecha Genre and its Apocalyptic Bodies2023 · OpenAlex
  45. Ngu-Vi-Tieu-Khat decoction, a Vietnamese traditional medicine, possesses hypoglycemic and hypolipidemic effects on streptozotocin-induced type-2 diabetic rat model2023 · Crossref
  46. Nhận Định Của Các Tu Sĩ Dòng Đức Mẹ Người Nghèo Đối Với Những Người Nghiện Ma Túy Đã Cai Tại Cơ Sở Nhà Dòng2023 · Crossref
  47. NIAAA updates information on alcohol use treatment2023 · Crossref
  48. Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study2023 · OpenAlex
  49. Nicotine Addiction, Alcohol Use Disorder and Bipolar Disorder2023 · Crossref
  50. Nicotine Delivery of a Menthol-Flavored Heat-not-Burn Tobacco Product During Directed Use2023 · Crossref
  51. Nicotine dependence and associated factors among persons who use electronic e-cigarettes in Malaysia - an online survey2023 · Crossref
  52. Nicotine on the developing brain2023 · OpenAlex
  53. Nicotine Pouch Awareness and Use Among Youth, National Youth Tobacco Survey, 20212023 · Crossref
  54. Nicotine receptor partial agonists for smoking cessation2023 · OpenAlex
  55. Nicotine receptor partial agonists for smoking cessation2023 · OpenAlex
  56. Nicotine: From Discovery to Biological Effects2023 · OpenAlex
  57. NIDA and NIAAA call for information on use of ‘preaddiction’2023 · Crossref
  58. NIDA and NIH invite research into drug‐checking tools2023 · Crossref
  59. NIDA study finds OD deaths more than tripled 35–44 year old in PPW women2023 · Crossref
  60. NIDA: Why injecting is more addictive than oral use2023 · Crossref
  61. Nigeria’s War Against Drug Abuse: Prevalence, Patterns, Ramifications, Policy and Multisectoral Response, Strategies and Solutions2023 · OpenAlex
  62. NIH ups its commitment to study harm reduction approaches2023 · Crossref
  63. NIST Mass Spectrometry Data Center standard reference libraries and software tools: Application to seized drug analysis2023 · OpenAlex
  64. Nitrazepam and 7-aminonitrazepam studied at the macroscopic and microscopic electrified liquid-liquid interface2023 · OpenAlex
  65. Nitrogen fertilization impact on hemp (Cannabis sativa L.) crop production: A review2023 · OpenAlex
  66. Nitrogen fertilization promoted microbial growth and N2O emissions by increasing the abundance of nirS and nosZ denitrifiers in semiarid maize field2023 · OpenAlex
  67. Nitrous Oxide Inhalant Abuse: Preliminary Results from a Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Physicians (2023)2023 · OpenAlex
  68. Nitrous oxide-induced myeloneuropathy: a case series2023 · OpenAlex
  69. Nitrous Oxide-Induced Subacute Combined Degeneration in a 38-Year-Old Pregnant Female After Recreational Use2023 · OpenAlex
  70. NLR- and mlo-Based Resistance Mechanisms against Powdery Mildew in Cannabis sativa2023 · Crossref
  71. NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine2023 · OpenAlex
  72. NMDA Receptor Glycine Binding Site Modulators for Prevention and Treatment of Ketamine Use Disorder2023 · Crossref
  73. NMDA Receptors in the Rat Paraventricular Thalamic Nucleus Reduce the Naloxone-induced Morphine Withdrawal2023 · Crossref
  74. No decline in drug overdose deaths in Norway: An ecological approach to understanding at-risk groups and the impact of interventions2023 · OpenAlex
  75. No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users2023 · Crossref
  76. No obvious effect on mortality from a patient choice reform expanding access to opioid disorder treatment – results from a natural experiment of policy change in Sweden2023 · Crossref
  77. No prescription? No problem: A qualitative study investigating self-medication with novel psychoactive substances (NPS)2023 · OpenAlex
  78. Noise dynamics in city nightlife: Assessing impact and potential solutions for residential proximity to pubs and bars2023 · Crossref
  79. Nomophobia among university students: Prevalence, correlates, and the mediating role of smartphone use between Facebook addiction and nomophobia2023 · OpenAlex
  80. Nomophobia – how smartphone addiction can affect social media behaviour and implemented communication strategy2023 · Crossref
  81. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma2023 · OpenAlex
  82. Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study2023 · Crossref
  83. Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors2023 · OpenAlex
  84. Non-Lethal Dose-Response Models Replace Lethal Bioassays for Predicting the Hazard of Para-Aminopropiophenone to Australian Wildlife2023 · Crossref
  85. Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort2023 · OpenAlex
  86. Non-pharmacological Interventions for Tobacco Cessation in India: A Systematic Review and Network Meta-analysis2023 · Crossref
  87. Non-Prescribed Substance Use during the First Month of Treatment by People Receiving Depot Buprenorphine for Opioid Use Disorder2023 · OpenAlex
  88. Non-Psychoactive Cannabinoid Modulation of Nociception and Inflammation Associated with a Rat Model of Pulpitis2023 · Crossref
  89. Non-Psychoactive Phytocannabinoids Inhibit Inflammation-Related Changes of Human Coronary Artery Smooth Muscle and Endothelial Cells2023 · Crossref
  90. Non-Targeted Metabolomic Profiling Identifies Metabolites with Potential Antimicrobial Activity from an Anaerobic Bacterium Closely Related to Terrisporobacter Species2023 · Crossref
  91. Nondisordered Cannabis Use Among US Adolescents2023 · Crossref
  92. Nonfatal Overdoses Among Pregnant Individuals With Opioid Use Disorder2023 · OpenAlex
  93. Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment2023 · Crossref
  94. Nonsmoking after simultaneous alcohol abstinence and smoking cessation program was associated with better drinking status outcome in Japanese alcohol-dependent men: A prospective follow-up study2023 · Crossref
  95. Non‐abstinent recovery in alcohol use disorder is associated with greater regional cortical volumes than heavy drinking2023 · Crossref
  96. Non‐alcohol substance use disorder after bariatric surgery in the prospective, controlled Swedish Obese Subjects study2023 · Crossref
  97. Non‐invasive assessment of cultivar and sex of Cannabis sativa L. by means of hyperspectral measurement2023 · Crossref
  98. Non‐uniform sampling to enhance the performance of compact NMR for characterizing new psychoactive substances2023 · OpenAlex
  99. Noribogaine effects on wakefulness and sleep2023 · OpenAlex
  100. Normative Misperceptions About Cannabis Use in a Sample of Risky Cannabis Users2023 · Crossref